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Abstract
Background:  Cerebral autosomal dominant arteriopathy with subcortical infarcts and
leukoencephalopathy (CADASIL) is increasingly recognized as an inherited arterial disease leading
to a step-wise decline and eventually to dementia. CADASIL is caused by mutations in NOTCH3
epidermal growth factor-like repeat that maps to chromosome 19. CADASIL cases have been
identified in most countries of Western and Central Europe, the Americas, Japan, Australia, the
Caribbean, South America, Tanzania, Turkey, South Africa and Southeast Asia, but not in Arabs.
Methods: We studied three families from Saudi Arabia (Family A), Kuwait (Family B) and Yemen
(Family C) with 19 individuals affected by CADASIL.
Results: The mean age of onset was 31 ± 6 and the clinical presentation included stroke in 68%,
subcortical dementia in 17% and asymptomatic leukoariosis detected by MRI in 15%. Migraine and
depression were frequently associated, 38% and 68% respectively. The mean age of death was 56
± 11. All NOTCH3 exons were screened for mutations, which revealed the presence of previously
reported mutations c.406C>T (p.Arg110>Cys) in two families (family A&B) and c.475C>T
(p.Arg133>Cys) mutation in family C.
Conclusion: CADASIL occurs in Arabs, with clinical phenotype and genotype similar to that in
other ethnic groups.
Background
Cerebral autosomal dominant arteriopathy with subcorti-
cal infarct and leukoencephalopathy (CADASIL) is
becoming the most common form of adult onset heredi-
tary syndrome characterized by recurrent transient
ischemic attacks (TIA) and strokes, leading to progressive
dementia, migraine with aura and psychiatric distur-
bances [1-3]. Symmetrical white matter abnormalities are
invariably seen, while small subcortical infarcts are often
reported [4]. The extent of the MRI lesions increases with
age. Atypical anteriopathy with electron-dense granular
deposition in the media of small cerebral arteries under-
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lies the pathology of this disorder [5]. This initial thicken-
ing and expansion of the extracellular matrix can be found
to a lesser extent in extracerebral arteries, such as skin arte-
rioles [6]. Mutation in the NOTCH3 gene is usually linked
to CADASIL [1]. NOTCH3 encodes a 300-kd transmem-
brane protein with a receptor and cell signal transduction
function. This receptor is expressed in vascular smooth
muscle cells [7]. Mutations are almost always mis-sense
mutations causing the loss or gain of a cysteine residue
and are detected in over 90% of patients [8,9]. All muta-
tions were located within the epidermal growth factor
(EGF) repeats in the extracellular domain of the NOTCH3
gene and a strong clustering of the mutations were
observed in exons 3 and 4 [8-10]. Thus, there are more
than 81 NOTCH3  mutations reported on the human
genome mutation database [11] to-date. Therefore,
CADASIL is far more common than previously perceived
and it may often be misdiagnosed because it can present
under various guises [10].
CADASIL cases have been identified in most countries of
Western and Central Europe, the Americas, Japan, Aus-
tralia, Tanzania, South America, the Caribbean, Turkey
[12], South Africa [6] and Southeast Asia [13-16]. To our
knowledge, there are no published reports of CADASIL in
native Arabs yet. Here we describe the clinical and genetic
findings in three families from various Arab countries.
Methods
Family enrollment
Requests to identify cases and participants in this study
was done through mailing a brief Inclusion Criteria form
(see below) for the disease to all members of the Pan Arab
Union of Neurological Sciences. Families were included
when an index case had both a history of transient
ischemic attacks (TIA) or subcortical stroke of unidenti-
fied etiology, positive family history of stroke with early
death or dementia compatible with autosomal dominant
traits, and a cranial MRI scan showing diffuse or focal
microangiopathic white matter abnormalities. Three fam-
ilies with pure ethnic background fulfilled the inclusion
criteria. Family (A) from Saudi Arabia, family (B) was
from Kuwait and family (C) was from Yemen. Affected
individuals, their parents (if alive) and siblings were stud-
ied in these families. This research followed the tenets of
the Declaration of Helsinki. All participants signed an
informed written consent, which was approved by the
King Faisal Specialist Hospital-Institutional Review Board
KFSH-IRB. The approved informed consent included an
approval for inclusion of family members in this study
and for publication of findings.
Clinical assessment
All subjects, their siblings and other available family
members (Figure 1) have had detailed clinical evaluations
and assessment of risk factors. Previous and current imag-
ing results were collected. In one family MRI brain scans
were performed in all sib ship of the index case (Family
B). Vascular dementia was diagnosed according to the
"NINDS-AIREN Criteria for the diagnosis of vascular
dementia" [17]. In summary, probably vascular dementia
includes: memory impairment, cognitive decline in one
or more domains, and presence of focal signs on neuro-
logical examination (gait problems, personality and
mood change and pseudobulbar involvement).
Sample collection and DNA extractions
Five ml of peripheral blood were collected in EDTA tubes
from all participating individuals after obtaining their
written informed consent. DNA was extracted from whole
blood samples of all CADASIL patients and their family
members using the PURGENE DNA isolation kit from
Gentra Systems (Minneapolis, USA).
Pedigree of the three Arab studied kindreds Figure 1
Pedigree of the three Arab studied kindreds. S: stroke, D: 
dementia, M: migraine, P: psychiatric manifestations. 
Number(s) at the top indicates age at death or at time of 
examination. Diagonal fill indicates asymptomatic positive for 
mutations. Horizontal fill indicates asymptomatic positive 
with abnormal brain MRI.BMC Medical Genetics 2007, 8:67 http://www.biomedcentral.com/1471-2350/8/67
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Mutation analysis of the NOTCH3 gene
DNA from patients and their families was amplified using
primers designed to amplify the 33 exons, including the
intron-exon boundaries, of the NOTCH3 gene. The same
amplification primers were also used for sequencing.
Sequencing was carried out using the Dynamic Termina-
tor Reagent Sequencing kit [Amersham Pharamcia, US].
The samples were then run on the DNA analyzer [Mega-
BACE 1000 Capillary system; Molecular Dynamics, Amer-
sham Pharmacia Biotech]. Data from the analyzer were
analyzed using the Chromas-Pro version 1.34 (Technely-
sium, Pty, Ltd, Australia). We also investigated the fre-
quency of each detected mutation in our normal controls
(see Table 1). In this study, we excluded known proven
silent-polymorphisms found in patients and controls
from reporting and further analysis.
Results
Nineteen (19) affected individuals, 9 males & 10 females,
were examined by at least one of the authors. The mean
age of onset was 31 ± 6 years. Stroke or TIA were noted in
68% of cases, the majority of episodes led to motor syn-
drome (hemiparesis, pseudobulbar palsy, dysphagia and
incontinence) followed by sensory deficit and ataxia. 22%
of examined patients had prominent cognitive decline
and met the diagnostic criteria for vascular dementia [17]
with stepwise deterioration, gait problems and urinary
incontinence. Depression was the prominent affective dis-
order (25%) and in few patients was the only presenting
symptom. Age of death was retrospectively identified and
the mean age of death was 56 ± 11 years in the 8 patients
studied. Migraine with aura was the predominant feature
in members of Family B and affected members had histo-
ries of at least one vascular headache attack starting in the
early 20s, followed by TIA or stroke 8 – 12 years later. One
individual with depression and one with psychosis and
ischemic changes in their MRIs (Figure 2a, 2b). Interfamil-
ial and intra-familial variability with regards to presenting
symptoms and of age at death was noted in most of the
participants.
The following is the clinical and molecular findings sum-
mary of the three (3) families studied.
Family A
The proband was examined at age 40 because of sudden
left-sided weakness. He has a history suggestive of multi-
ple attacks of TIA at age 37 and 38, and an episode of right
sided numbness at age 39. The proband father was
reported to have migraine attacks at age 33 and repeated
stroke starting at age 40. He died at age 58. His aunt had
stroke at age 40 and died at age 51 with dementing illness.
His sister had one episode of stroke at age 38, his brother
had multiple minor strokes, showed evidence of pseudo-
bulbar affects, and bilateral pyramidal findings leading to
abnormal gait at age 36. MRI brain for proband, his
father, sister and brother showed multiple ischemic
lesions bilaterally with marked brain atrophy in the
father. Sequencing of the NOTCH3  gene, revealed the
presence of heterozygous c.406C>T (p.Arg110>Cys) path-
ogenic mutation in exon 3 of the NOTCH3 gene. This
mutation was previously described [1] and was not
detected in 100 controls with matching ethnicity.
Family B
In this Kuwaiti family the proband had migraine in the
mid-20s, and multiple strokes were noted at age 28. The
mother had migraine and stroke in her early 30s and died
at age 53. Six out of eight siblings were affected; two were
asymptomatic with white matter disease on MRI, three
died at age 51, 53 and 60 respectively, with a history of
migraine, stroke and dementia. One sister with multiple
strokes died at age 51. None had hypertension or diabetes
and all blood tests and cardiac evaluations were normal.
The older sister had one daughter with migraine and
stroke starting at age 30, while the other had experienced
migraine with aura at age 21. Sequence analysis of the
NOTCH3  gene; revealed the presence of heterozygous
c.406C>T (p.Arg110>Cys) pathogenic mutation in exon
3. This is a previously reported mutation that was not
found in 100 controls of matching ethnicity.
Family C
A 48-year old man from southern Yemen, known to have
rheumatoid arthritis was seen with a five-month history of
repeated attacks of numbness right side. He has three
other sisters. A Sister aged 52 had a long-standing history
of migraine, another had multiple strokes starting at age
36. The father died at age 58 because of dementia and
Table 1: Summary of the NOTCH3 mutations detected in our CADASIL families
Family Ethnicity Mutation detected Exon Amino acid change Domain Frequency in our controls (n= 100)
A Saudi c.406C>T 3 p.Arg110>Cys EGF2 ND
B Kuwait c.406C>T 3 p.Arg110>Cys EGF2 ND
C Yemen c.475 C>T 4 p.Arg133>Cys EGF3 ND
EGF = Epidermal Growth Factor Like Repeats.
ND = not detectedBMC Medical Genetics 2007, 8:67 http://www.biomedcentral.com/1471-2350/8/67
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repeated stroke. An uncle died at age 60 after a 12-year his-
tory of stroke and vascular dementia, while an aunt died
at age 63 with accelerated stroke over four years. MRI from
the proband and his sister showed multiple ischemic
white matter lesions (Figure 2c, 2d). Sequencing the
NOTCH3  gene revealed the presence of a previously
known heterozygous mutation c.475C>T (p.Arg133>Cys)
in exon 4 [1]. This mutation was not found in our con-
trols. Table 1 summarizes the molecular findings in all
families.
Discussion
The families described in this report showed various char-
acteristics that are typical of CADASIL, an autosomal
dominant syndrome, with migraine, recurrent ischemic
strokes, cognitive impairment, depressive disorder and
premature death within 10 – 20 years after onset [4].
CADASIL affects young and old adults, irrespective of vas-
cular risk factors. In two of our families the affected sib-
ling of probands had migraine with aura in their early 20s,
followed by recurrent ischemic attacks in their mid 30s.
Young onset of this syndrome had been reported previ-
ously [12,16]. The clinical course of the disease is hetero-
geneous, even within the same family as noted previously
[1,5] (Figure 1).
MRI findings in our families include focal lacunar infarct
and diffuse T2 weighted hyperintensity, usually including
the temporal lobes and external capsules (Figure 2b, 2d).
Positive MRI findings in asymptomatic individuals or in-
patients who presented with depression or a psychiatric
problem (Family B) indicated that NOTCH3 gene signal-
ling may start early and may have different clinical presen-
tations. The reported penetrance of MRI abnormalities is
usually complete after age 35 and the mean age of clinical
onset was 45 ± 10 years [3,4].
NOTCH3  mutations have been identified as a genetic
cause of CADASIL. Numerous mutations in this gene have
been described in recent years along with genetic hetero-
geneity of the disease [9]; however, until now no geno-
type-phenotype relationship has been described [9].
The molecular findings in our families are in agreement
with previous studies in other populations from different
ethnic groups. All reports have found exon 4 to be the
most common site of mutation and exon 3 to be the sec-
ond most common site [7,8,18].
CADASIL has been reported across various ethnic groups,
with predominance among the French, German and Ital-
ian populations [2,6]. It has seldom been reported from
Asia [14]. Families from Japan [6], Korea [13], Taiwan
[14], Turkey [12] and Thailand [15] have also been
reported.
Conclusion
We conclude that CADASIL can be seen in Arabs, and is
probably under-diagnosed with similar clinical and
genetic presentation as seen in other ethnic groups.
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